Skip to main content
. 2020 Mar 15;12(3):875–888.

Figure 2.

Figure 2

miR-212-3p can downregulate MAP3K3 expression in high-grade serous ovarian cancer (HGSOC) cells. (A) mRNA and protein expression of miR-212-3p and MAP3K3 in six ovarian cancer cell lines and 293T cells. MAP3K3 expression was remarkably decreased after transfection with miR-212-3p mimics in A2780 (B) and SKOV3 (C) cells at both the mRNA and protein levels. MAP3K3 expression was significantly increased after transfection with a miR-212-3p inhibitor in OV2008 (D) cell lines.